NCT06090097 Knee Biofeedback Rehabilitation Through Game Therapy
| NCT ID | NCT06090097 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Barron Associates, Inc. |
| Condition | Knee Osteoarthritis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-09-04 |
| Primary Completion | 2026-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-09-04 with a primary completion date of 2026-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to learn about the effect of video-game based rehabilitation exercise for patients with knee osteoarthritis. The main question the study aims to answer is: do patients who exercise with the game have better functional outcomes and engagement compared to patients who do conventional exercise? Participants will complete 10 weeks of physical therapy exercise sessions that focus on quadriceps strengthening. Two sessions per week will be conducted in the clinic, and one session will be conducted at home each week. The interventional group will conduct all exercises using the KneeBRIGHT EMG sensors and game software. The control group will conduct all exercises following a standard physical therapy regimen. Researchers will compare knee function and engagement between the group who uses the game, and the group who does conventional exercise.
Eligibility Criteria
Inclusion Criteria: * diagnosis via x-ray, with a score of at least 2 (out of 4) on the Kellgren-Lawrence OA scoring system; independent ambulation without assistive device Exclusion Criteria: * individuals who have psychiatric or cognitive impairment (e.g., dementia) that interferes with their ability to follow instructions or provide voluntary consent; symptomatic spine, hip, ankle, or foot disease other than OA that would interfere with assessment of the knee.
Contact & Investigator
Eileen Krepkovich, MS
PRINCIPAL INVESTIGATOR
Barron Associates
Frequently Asked Questions
Who can join the NCT06090097 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 75 Years, studying Knee Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06090097 currently recruiting?
Yes, NCT06090097 is actively recruiting participants. Contact the research team at krepkovich@barronassociates.com for enrollment information.
Where is the NCT06090097 trial being conducted?
This trial is being conducted at Chapel Hill, United States.
Who is sponsoring the NCT06090097 clinical trial?
NCT06090097 is sponsored by Barron Associates, Inc.. The principal investigator is Eileen Krepkovich, MS at Barron Associates. The trial plans to enroll 60 participants.